Nerve Regeneration Companies

Epineuron Enrolls First Patient in Nerve Regeneration Study: Canadian company Epineuron has begun enrolling patients in a large-scale trial (REGAIN) testing their PeriPulse device for acute peripheral nerve injury treatment. This FDA breakthrough designated device uses electrical stimulation for a single hour near the injury site. This marks the largest medical device study for nerve regeneration and could significantly advance treatment options.

Medtronic and Boston Scientific Receive FDA Approvals for Neuromodulation Devices: Medtronic received FDA approval for two neurostimulators (Intellis and Vanta) in 2022, used to manage chronic pain associated with diabetic peripheral neuropathy.

Boston Scientific received FDA approval for Vercise Neural Navigator with Stimview XT software in 2022, which aids deep brain stimulation therapy for Parkinson's disease.These approvals highlight the growing role of neuromodulation technologies in nerve regeneration and treatment of neurological disorders.

Neuronetics Partners with River Region Psychiatry Associates: Neuronetics Inc. established a partnership with RRPA, a leading US mental health provider, in 2021. This deal makes Neuronetics the exclusive supplier of transcranial magnetic stimulation (TMS) equipment to RRPA and its clinics, further expanding their reach in treating neurological conditions.

Abbott Launches NeuroSphere Virtual Clinic: Abbott introduced its NeuroSphere Virtual Clinic in 2021, enabling remote therapy and management of neuromodulation patients. This platform addresses the increasing demand for telemedicine solutions in healthcare, particularly for managing chronic conditions affecting nerve function.

• GiMer Medical


• Medtronic PLC


• Abbott Laboratories


• Collagen Matrix


• NeuroSigma


• Boston Scientific Corporation


• Intergra LifeSciences


• Nerve Corp


• NeuroPace


• AxoGen


• KeriMedical


• Polyganics


• Synapse Biomedical